Work

A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential

Year: 2005

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2005.04.021

Authors: Neil J. Press, Roger J. Taylor, Joseph D. Fullerton, Pamela Tranter, Clive McCarthy, Thomas H. Keller, Lyndon Brown, Robert Cheung, Julie Christie, Sandra Haberthuer, Julia D.I. Hatto, Mark Keenan, Mark K. Mercer, Nicola E. Press, Helene Sahri, Andrew R. Tuffnell, Morris Tweed, John R. Fozard

Institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research, Novartis Institute For Tropical Diseases

Language: English

Topic: Adenosine and Purinergic Signaling

Subfield: Physiology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2109980299

FWCI: 1.861

Cites: 29

Cited by: 31

Related to: 10